ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PKOH vs TMO // EV/EBITDA & P/E VALUATION

Park-Ohio Holdings Corp. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PKOH 4 — TMO 6
▲ EV/EBITDA & P/E VALUATION LEADER: PKOH
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PKOH VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PKOH TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 17.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 15.60% 9.30% +6.30 PKOH /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 6.0x 30.4x -24.40 PKOH /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin 4.10% 17.40% -13.30 TMO /operating-margins <GO>
Net Profit Margin 1.50% 15.10% -13.60 TMO /net-margins <GO>
Revenue Growth (YoY) -3.40% 3.90% -7.30 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 1.20% 0.24% +0.96 PKOH /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.2 62.9 -24.70 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 25.5x 36.3x -10.80 PKOH /forward-pe <GO>
Enterprise Scale & Market Cap $652.1M $262.22B -$261.57B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PKOH REV TMO REV PKOH GROSS % TMO GROSS % PKOH FCF TMO FCF
FY 2025 $1.60B $44.56B 17.0% — — $6.29B
FY 2024 $1.66B $42.88B 17.0% — — $7.27B
FY 2023 $1.66B $42.86B — — — $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PKOH // BETA —
TMO // BETA 0.94